Search

everythinglearnresearchcommunity

for

Search:↓

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

K31 can identify clear secretory cells in human sweat glands.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Basal cell carcinoma cases are rising globally.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

LRIG1 is linked to better survival in Merkel cell carcinoma.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.